Renal Sympathetic Denervation Improves Cardiac Function Through Attenuating Myocardial Apoptosis After Myocardial Infarction In Rats

Shun-Xiang Luo,Xiao-Xin Zheng,Shang-Hua Xu,Wen-Liang Zhong,Xue-Jun Jiang
2016-01-01
Abstract:Objective: This study aims to investigate whether renal sympathetic denervation (RSD) can reduce myocardial apoptosis after myocardial infarction (MI) and explore the potential mechanisms. Methods: Six-four male Sprague-Dawley rats were randomly assigned to sham, RSD, sham+MI and RSD+MI group. Three days after sham or RSD operation, MI was induced. Plasma angiotensin II, aldosterone and noradrenaline, left ventricular (LV) function, myocardial apoptosis rate, the mRNA and protein expression levels of apoptotic factors (including bax, bcl-2 and caspase3), and transforming growth factor beta 1 (TGF-beta 1) in LV were evaluated 4 weeks post-MI. Results: Rats in the sham+MI group showed asignificantly deterioration in LV function and hemodynamics, which were improved when RSD performed before MI. The myocardial apoptosis rate, along with the mRNA and protein levels of bax, cleaved caspase-3, in the RSD+MI group were significantly lower when compared with sham+MI group, while the levels of bcl-2 were significantly higher. The mRNA and protein levels of TGF-beta 1 in LV and plasma angiotensin II, aldosterone and norepinephrine levels significantly were increased after MI, while the levels decreased following RSD treatment. Conclusions: The positive effects of RSD on cardiac dysfunction post-MI may be partly regulated via attenuating myocardial apoptosis through downregulation of TGF-beta 1.
What problem does this paper attempt to address?